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ABSTRACT 
The reaction in acidconditions of Leptocarpin 1, a compound with antitumor 
activity, formed two new isomeric products, 8β-angeloyl-1β,3β-dihydroxy-4,10-
dimethyl,-∆11(13) methylen-4Z,9Z-dieneheliangol-6,12-olide 2 and 8β-angeloyl-
1β,3β-dihydroxy-4-methyl-∆11(13),∆11(14)-dimethylen-4Z-eneheliangol-6,12-olide 
3, whose structures reported in this study were established by spectroscopy (1H-
NMR, 13C-NMR, MS and IR) and confirmedthrough ROESY experiments and 
theoretical studies by molecular mechanics. The in vitro cytotoxicity of these 
isomeric compounds was less active than leptocarpin, showing the importance of 
the oxirane ring in the biological activity. Cytotoxic activity was measured in six 
cancer cell lines.  
Keywords: Conformational analysis; Heliangolide; Sesquiterpene lactones; 
Cytotoxicity. 
 
INTRODUCTION 
  
"Palo negro" is a native shrub of southern Chile, originally called Cüdu-mamëll (in 
Mapudungun) by the Mapuche people of Chile. Its scientific name is Leptocarpha 
rivularis1 and belongs to the Compositae family, to the Heliantheae tribe, 
presently classified as Asteraceae2. The secondary metabolites that characterize 
this family are acetylenics, sesquiterpene and sesquiterpene lactones. They also 
contain essentials oils, flavonoids, and triterpenes but not tannins, iridoids nor 
amino acids nonprotein3. The extracts of plants containing antineoplasic activity 
have been profusely studied in the last decades4-10. A high percentage of the 
evaluated sesquiterpenes are potential inhibitors of cellular growth in numerous 
tumor models11-14 and it has been suggested that the high cytotoxicity of some 
lactones may be due to their capacity to inhibit the synthesis and/or the 
transcription of DNA15. On the other hand, the protein synthesis is also 
affected16-17 and it has been dionstrated that the activity of sesquiterpene 
lactones-α,β-unsaturated is associated with the selective alkylation through a 
Michael-type reaction of biological nucleophiles such as L-cysteine or enzymes 
that control the cellular division. It is likely that these lactones inhibit the 
selective incorporation of amino acids18-22. The study of the effect of leptocarpin 
(Figure 1), a heliangolide type lactone isolated from Leptocarpha rivularis23, on 
the macro-molecule synthesis of DNA, RNA and proteins in HeLa cell cultures24, 
using Alonso's method25 showed that leptocarpin and its corresponding 
acetylated derivative inhibit approximately 50% of the incorporation of 35S-
Methionine without affecting the incorporation of (methyl-3H)-Thymidine and 
(5,6-3H)-Uridine at a concentration of 3.0 x 10-5 M. However, at concentrations 
lower than 6.5 x 10-6 M, it shows cytostatic effects. The reduction of exocyclic 
double bond in ∆11,13Causes inactivation of the biological activity of leptocarpin.26  
 
 
In this paper we report the hiisynthesis of two sesquiterpene lactones leptocarpin 
derivatives that were designed to prove the importance of the oxirane ring in the 
biological activity of leptocarpin on cell uptake and cytotoxicity. These studies 
have provided fundamental data to asses whether leptocarpin could be a 
promising anticancer drug. 
EXPERIMENTAL 
Experimental procedures. 
The 1H-NMR spectra were taken in a spectrometer Brüker Avance DRX-400 at 
400 MHz in CDCl3. and 13C NMR (100 MHz).The IR spectra were obtained in a 
Perkin Elmer 200 spectrometer. The mass spectra (low resolution) were 
measured in a Vg-Micromass ZAB-2F spectrometer. 
General Extraction Details.  
Leptocarpin (1), is isolated and purified through usual laboratory techniques, 
extraction by ethyl acetate or ethanol and the obtained extract is purified using 
technical chromatographic methods27 (silica-gel columns and solvents mixes of 
increasing polarity). 
Hiisynthesis of compounds 2 and 3.  
The transformation of Leptocarpin was obtained through the acid treatment of 
the leptocarpin with saturated chloroformic solution with HCl, to mimick what 
would happen when the drug encounters the gastric acid pH (Figure 1).Five 
hundred milligrams of leptocarpin were treated with a saturated solution of HCl in 
CHCl3, shaking during 2 hours in an ice bath at 0ºC. It was concentrated in a 
rotary evaporator, washed with a saturated solution of NaHCO3, and then with 
distilled water. The latter was extracted with chloroform and dried with 
anhydrous Na2SO4. The products were separated and purified by preparative 
chromatography in silica-gel, eluted in a mixture of hexane/ethyl acetate (8:2), 
yielding 205 mg of recovered leptocarpin and 72 mg of a mixture of 2 and 3. 
Attipts of purification by HPLC (Grad. Acetonitrile/H2O) failed. Analytical samples 
were obtained by several HPLC runs and preparative chromatography on Si-gel. 
The analysis of mixtures28 by H-NMR revealed 6.9% of 3. 
8β-angeloyl-1β,3β-dihydroxy-4,10-dimethyl,-∆11(13)0000000 methylen-
4Z,9Z-dieneheliangol-6,12-olide(2).  
IR νNujolcm-1 : 3450-3400 GRATIS 3450-3400  (broad), 1772, 1736, 1659. 
MS m/z (rel.int.): 362 M+ ( 6 ), 99 ( 10 ), 83 ( 98 ), 71 (12 ), 55 ( 100 ).1H-
NMR, d: 1.80 (H-15,d, J=1.5Hz); 1.83 (H-14,d, J= 1.5Hz); 1.90 (H-5', d , J= 
1.5Hz); 1.98 (H-4´, d, J=7.0Hz);2.19 (H-2, m); 3.12 (H-7, m); 4.53 (H-3, m); 
4.80 (H-1, dd, J= 1.3, 3.5Hz); 5.30 (H-9, d, J= 9.0Hz); 5.42 (H-5, dd, J= 1.5, 
3.5Hz); 5.80 (H-6, ddJ= 3.5, 10Hz); 5.95 (H-8, m, J= 3.97 and 9.24);6.10 (H-
13a, d, J= 1.1Hz); 6.12 (H-3', dd, J= 1.5, 7.0Hz); 6.25 (H-13b, d, J= 1.1Hz).13C-
NMR : δ:C-4', 16.89; C-14 20.71; C-15, 23.29; C-5', 26.86; C-2, 41.08; C-7, 
50.25; C-8, 75.02; C-3, 76.68; C-1, 77.00; C-6, 77.32; C-9, 121.87; C-13, 
122.81; C-3', 122.85; C-5,127.13; C-11, 135.96; C-2', 139.82; C-4, 144.29; C-
10, 146.29; C-1'167.16; C-12, 169.80 
8β-angeloyl-1β,3β-dihydroxy-4-methyl-∆11(13),∆11(14)-dimethylen-4Z-
eneheliangol-6,12-olide ( 3 ) 
IR νNujolcm-1 : 3445-3390 GRATIS 3445-3390  (broad), 1768, 1757, 1659. 
MS m/z (rel.int.): 362 M+ ( 4 ), 182 ( 4 ) 99 ( 14 ), 83 ( 89 ), 71 (12 ), 55 ( 100 
).1H-NMR, δ: 1.80 (H-15, d, J= 1.5Hz); 1.81 (H-5, d, J=1.5Hz); 1.96 (H-4', d, 
J=7.0Hz); 2.08 (H-2, m); 2.55 (H-9, m);2.90 (H-9´, m); 3.20 (H-7, m); 4.10 
(H-3, dd,J= 8.0, 0.3Hz); 4.50 (H-1, dd, J= 1.3, 3.5Hz); 5.12 (H-14, d, J= 1.3Hz); 
5.16 (H-8, m); 5.32 (H-5´, d, J= 1.5H; 5.50 (H-14´, d, J= 1.3Hz); 5.75 (H-13a, 
d, J= 1.3Hz); 6.10 (H-3', m); 6.30 (H-6, m, J= 0.8, 3.0Hz); 6.33 (H-13b, d, J= 
1.3Hz). 13C-NMR : δ: C-5', 18.92; C-15, 20.29; C-4', 22.89; C-9, 37.68; C-2, 
41.44; C-7, 47.04; C-3, 76.68; C-1, 76.99; C-6, 77.20;C-8, 77.31; C-14, 
117.90; C-13, 124.31; C-3', 126.31; C-5, 127.10; C-11, 137.41; C-2', 140.17; 
C-4, 141.71; C-10, 143.78; C-1', 166.68; C-12, 169.73. 
General Cell Culture Details.  
The studies on biological activity took place on cell cultures29, such as NSO-2, 
CHO, P-815, HeLa, J 774.2, 4 FIO-67, SK-Hep-1. The cell lines were rioved from 
liquid nitrogen, thawed and cultivated in RPMI 1640 culture medium (Chi.Sigma, 
USA) at 37ºC in a humid atmosphere with 5% of CO2. The culture was placed in 
40 mL cell culture flasks. Once the cultures dionstrated a suitable growth, the 
cells were obtained by centrifugation (in the case of the adherent cultures, these 
were treated previously with Trypsin to detach the cells from the flasks). 
Following the centrifugation, the supernatant was discarded, the cells were 
suspended in 3 mL of RPMI 1640 medium with 10% of fetal bovine serum and 
antibiotics, counted, assessed for viability and incubated at a concentration of 
2.5x105 live cells/mL30-34. 
Cell Uptake Studies. 
The experiments of 3H-Thymidine, 3H-Uridine and 3H-Leucine uptake to DNA, 
RNA and proteins in the different cell lines with and without the studied 
compounds were carried out using 200 mL cell suspensions, plated out and 
incubated for 24 h at 37°C, in 5 % CO2. Then, sesquiterpene lactones were 
added and incubated for further 72 h. Before culture termination, 0.2 µCi of 3H-
Thymidine, 3H-Uridine and 3H-Leucine were added to each well respectively. After 
incubation, the cells were harvested onto a crystal filter paper using Multimash 
Harvested Dynatech Systi and processed for liquid scintillation counting 
(scintillation counter Packard instrument)35. The liquid scintillation contained 
0.5% of 2.5-difeniloxazol (PPO, Sigma Chiical Co) and 0.025% of 2,2'-fenilen bis-
(5-feniloxazol (POPOP, Sigma Chiical Co), in suitable solvent. The results were 
obtained in triplicate, expressed in counts per minute (cpm) and plotted using 
the program Graph Pad Prism 4.0. 
Cytotoxicity Experiments.  
Leptocarpin and its synthetic products were assayed for cytotoxic activity against 
SK-Hep-1 and HeLa cells.Cells (2.5 x 105 cells/mL) were cultivated previously on 
plastics plates of 35 mm (Falcon) in the culture medium described. Cells were 
allowed to proliferate for 24 h and then treated with leptocarpin and its synthetic 
products 2+3. The cultures were treated with trypsin at different times post 
treatment, suspended in 1mL of phosphate buffered saline (PBS) and the number 
of cells alive and dead was determined in aliquots of the cellular suspension. A 
mixture of 100 µL of cells suspension and 900 µL of trypan blue 0.1 % in PBS 
were incubated for five minutes. The total number of cells and the number of 
dead cells and stained with the vital dye were determined using a Neubauer 
chamber (Assisant, Thoma model, Germany) under a microscope (Baush and 
Lomb, model 313364, Rochester, NY/USA). 
Interestingly, for a same concentration of leptocarpin, a suspension of 2.25 x 105 
cells (100 µL) showed 66% cellular death, while with a suspension of 1.25 x 105 
cells (50 µL) an 83% of inhibition was achieved. The treatment with 2+3 
compounds, showed a cellular death of 34% and 8% respectively under the 
same conditions. (Table 5, Figure 8) respectively).  
RESULTS AND DISCUSSION 
Design and Synthesis of Derivatives.  
The Figure 1 shows the target products of the synthesis used in this study.  
The opening of the oxirane ring was designed to prove the importance of this 
structural characteristic in the biological activity and hence to dionstrate if the 
human gastric acid pH is able to alter the leptocarpin structure. In order to 
determine the stereochiical course of the reaction, leptocarpin 1, was added to 
chloroform saturated with HCl at 0ºC for two hours.Analysis of the NMR spectrum 
of the crude product showed the presence of a significant number of impurities in 
addition to signals arising from 2 and 3. Purification of the crude product by silica 
gel column chromatography allowed to recover non reacted material and to 
isolate a mixture of 2 and 3. Purification of this mixture to obtain analytical 
samples of 2 and 3 by HPLC was difficult due to the close elution of these 
products and therefore, the isolation of pure analytical samples from the mixture 
required multiple cycles of HPLC and preparative TLC.  
The structures were determined by H-RMN, 13C-RMN and mass spectrometry, like 
the isomeric heliangolides ones, 8β-angeloyl-1β,3β-dihydroxy-4,10-dimethyl,-
∆11(13) methylen-4Z,9Z-dieneheliangol-6,12-olide (2) and 8β-angeloyl-1β,3β-
dihydroxy-4-methyl-∆11(13),∆11(14)-dimethylen-4Z-eneheliangol-6,12-olide (3). 
The conformational analysis took place in CDCl3 solution through ROESY 
experiments, being 2 of CC (Chair-Chair) type and 3 of TT type (Twist-Twist) 
which agrees with the theoretical studies of molecular mechanics using Hyperchi 
MM2 program. (Figure 2). 
 
 From a theoretical point of view, leptocarpin under acid conditions can produce 
two types of cyclation products. First, an eudesmanolide type lactone by attack 
of the double bond ∆4,5 on C10 (6-Exo-Tet) producing the opening of the 
oxirane ring (Figure 3). The second product could be a guaianolide type lactone 
produced by the binding of carbons C5-C1 (5-Exo-Tet) as a consequence of the 
double bond ∆4,5 attack on C136. Nevertheless, this did not happen and a 
possible interpretation could be that interatomic distances C5-C10 (3.94 Aº) and 
C5-C1 (3.26 Aº) could be too far to allow the cyclation in each case. 
   
 
Contrary to the previous hypothesis, the acid treatment of leptocarpin (1) 
through the opening of the oxirane ring led to the formation of two heliangolide 
isomers, 8β-angeloyl-1β,3β-dihydroxy-4,10- dimethyl,-∆11(13) methylen-4Z,9Z-
dieneheliangol-6,12-olide (2) and 8β-angeloyl-1β,3β-dihydroxy-4-methyl-∆11(13), 
∆11(14) -dimethylen-4Z-eneheliangol-6,12-olide (3)whose structures were 
confirmed by spectroscopy. 
The conformational analysis of 2 and 3 was developed through ROESY 
experiments and molecular mechanics using the Hyperchi program. Thus, in 
ROESY experiments (Figure 2), they iphasize the interactions between protons 
H1-H2b, H2β-H3, H5-H7 and H15, H8-H13, H9-H14, and protons of methyl, 
H14-H15, and between protons of the angeloyl group H3´-H4´ and H3´-H15´. 
These interactions would be possible if 2 had a CC conformation as shown in 
Figure 2. 
On the other hand, the study of Molecular Mechanics through Hyperchi MM2 
program (Figure 2) is coincident with the ROESY experiment. Of all the possible 
conformations, the CC shows the least conformational energy value that 
corresponds to 37.929863 Kcal/mol (Grad. 0.086). 
With respect to the conformational study of 3 it is clearly observed in ROESY 
experiment the interactions between protons H1-H7, H1-H15, H2a-H3, H3-H15, 
H15-H5, H5-H7, H8-H9a, H8-H13b, H8-H14 and between H9a-H13b. Finally, the 
proton interactions of the angeloyl group H3´-H4´and H3´-H15´are also 
observed. All these interactions agree with a conformation TT as shown in Figure 
2. 
The theoretical study by Molecular Mechanics of 3, once again is consistent with 
the ROESY experiment since of all the possible conformations the most stable is 
TT conformation, with a conformational energy of 44.954205 Kcal/mol (Grad. 
0.09217). 
Solubility of compounds.  
Leptocarpin (1) and its derivative compounds (2), (3) are soluble in dimethyl 
sulfoxide (DMSO) but insoluble in water. Aqueous DMSO is often used for the 
dilution of poorly water soluble compounds to in vitro cytotoxicity assays37, up 
to a final concentration less than 5% of DMSO. Compounds 1, 2 and 3 were 
soluble in 0.1% aqueous DMSO, which allowed us to perform in vitro biological 
studies on these compounds.The biological activity studies were carried out with 
the product mixture 2 and 3. 
Cell Uptake Studies. 
The effect of leptocarpin and its acidic derivatives mixture on DNA, RNA and 
protein synthesis in five cancer cell lines,P-815, NSO-2, J 774.2, 4FIO-67, CHO, 
was examined by 3H-thymidine (Table 1, Figure 4), 3H-uridine (Table 2, Figure 5) 
and 3H-leucine uptake assays (Table 3, Figure 6), respectively.  
Table 1. (3H)-Thymidine uptake by different cell lines. 
 
Cell lines RPMI(cpm) Lep (cpm) 2+3 Mixture (cpm) 
 
P-815 80437 ± 3061 75414 ± 2734 75414 ± 2734 
NSO-2 23234 ± 1778 23717 ± 2736 22250 ± 1713 
J 774.2 41134 ± 1698 29843 ± 2876 22250 ± 
1713 
4FIO -67 20733 ± 2481 15454 ± 2118 17416 ± 2478 
CHO 29775 ± 664.7 29970 ± 1045 30303 ± 1531 
 
 
 
  
Table 2.(3H)-Uridine uptake by different cell lines. 
 
Cell lines RPMI (cpm) Lep (cpm) 2+3 Mixture (cpm) 
 
P-815 65416 ± 1416 65007 ± 2298 61765 ± 1835 
NSO-2 36055 ± 2683 35852 ± 1798 33996 ± 1554 
J 774.2 28115 ± 2543 28029 ± 1229 27714 ± 1932 
4FIO -67 27328 ± 2565 27501 ± 8808 27260 ± 2607 
CHO 5369 ± 691.4 5729 ± 592.6 5632 ± 531.1 
 
   
  
Table 3. (3H)-Leucine uptake by different cells lines. 
 
Cell lines RPMI (cpm) Lep (cpm) 2+3 Mixture (cpm) 
 
P-815 54343 ± 3922 26237 ± 1836 39477 ± 1300 
NSO-2 29952 ± 3331 8650 ± 1643 23917 ± 3184 
J 774.2 9964 ± 1651 4167 ± 294.3 7153 ± 860.6 
4FIO -67 22022 ± 1933 11650 ± 1587 18343 ± 1027 
CHO 6110 ± 871.2 2811 ± 215.9 3999 ± 174.9 
 
   
 
The results show that in all cancer cell lines investigated, the 3H-thymidine and 
3H-uridine uptake were not affected by leptocarpin or its derivatives. Leptocarpin, 
however and clearly at a lesser extent its derivatives 2 and 3, inhibited the 3H-
leucine incorporation in every cancer cell lines examined. On the other hand, an 
increase in the concentration of leptocarpin or its derivatives had no effect on the 
thymidine and uridine uptakes.  
Cytotoxicity Studies.  
Leptocarpin (1) was assayed for cytotoxic activity against human 
adenocarcinoma cell lines (SK-Hep-1).One hundred µl of cells suspension were 
mixed with 900 µL of 0.1% trypan blue in PBS and incubated with leptocarpin for 
five minutes. The total cell count and the number of cells stained with trypan 
blue dye were determined using a Neubauer Chamber. 
The effect of the Leptocarpin dose,in human liver adenocarcinoma cells SK-Hep-
1, at different times of incubation was studied over a 48 hours period. 
Leptocarpin at 5.0x10-5 M induced a riarkable cytotoxic effect (12% of cell 
viability at 24 h); at 5.0x-4 M it was cytotoxic showing cytolisis and cellular death 
a few hours following treatment (2.73% of cell viability at 24 h). At a 
concentration of 5.0x10-6 M it showed a cytostatic effect with IC50 value of 5 µM 
at 48 hours of treatment (Table 4 and Figure 7). The dose-response curves for 
the treatment of SK-Hep-1 cells with leptocarpin (1) for 24, 36 and 48 h are 
shown in Figure 7. It is clear that longer exposure times lead to increased cell 
death with very little reduction in viability observed in the cells treated just for 
24 h with 0.1% DMSO and leptocarpin 5x10-6 M. The cells treated with 
leptocarpin 5x10-5 M and 5x-4 M for 24 to 48 h showed similar levels of viability 
with very little cellular survival (12% and 2.73% of viability respectively at 24 h 
treatment). The cells treated for 48 h displayed 50% viability at a concentration 
of 5x10-6 M of leptocarpin (1). 
Table 4. Cytotoxicity of Leptocarpin on human 
adenocarcinome SK-Hep-1 cells (1.8x105 cells).  
 
Treatment 
hours 
0.1% Aqueous 
DMSO/Viability 
Lep 5.0x10-
6 
M/Viability 
Lep 
5.0x10-5 
M/Viability 
Lep 5.0x-4 
M/Viability 
 
24 89.9±1.88 86.2±2.193 12.0±1.06 2.73±0.21 
36 91.4±2.61 56.1±1.62 7.56±0.58 1.50±0.26 
48 90.1±2.84 46.9±1.81 2.56±0.50 0.93±0.15 
 
   
 The ability of leptocarpin (1) to inhibit the growth of human tumor cell lines was 
also assessed. HeLa cell suspensions of 2.25x105 and 1.25x105 cells exposed to a 
leptocarpin concentration of 3.0x10-5 M showed 34% and 16% cell viability, 
respectively, dionstrating the effectiveness of leptocarpin in the primary stages of 
a tumor. Using compounds 2 and 3 the results were 66% and 92% cell viability 
for the same cell suspensions. (Table 5, Figure 8). 
Table 5.Cytotoxic effect of Leptocarpin 3.0x10-5 M on 
two different HeLa cell suspensions.  
 
HeLa 
Cells RPMI/Viability Lep/Viability 
2+3 
Mixture/Viability 
 
2.25x105 96.17±2.12 33.83±3.24 66.03±2.25 
1.25x105 96.03±1.06 15.87±2.80 92.2±1.83 
 
 
 CONCLUSIONS 
The transformation of leptocarpin is a relative straightforward process without 
any major technical problis for its synthesis, except for the separation and 
purification of the products. 
DNA and RNA synthesis are not affected by Leptocarpin and the synthetic 
products therefore, its biological activity is not at this level. Leptocarpin produces 
a marked effect on the protein biosynthesis at a different extent in cancerous 
cellular lines and on the other hand, the synthetic products 2+3 have very low 
effect in comparison to leptocarpin thus dionstrating the importance of the 
oxirane ring for the biological activity. 
The effectiveness of the results could determine that the leptocarpin is an 
antineoplasic agent of natural origin which can be used in different types of 
neoplasia. 
The behaviour of Leptocarpin in an acid environment allows us to think that this 
molecule is sensitive to acid conditions and therefore as a possible future drug, it 
should not be administered orally, unless it is protected from gastric acid; this is 
why it is transformed into heliangolides structures with decreased biological 
activity. 
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